NHS National Generic Pharmaceuticals Wave 14b

NHS National Generic Pharmaceuticals Wave 14b<br/>Offer reference number: CM/PHG/22/5668<br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Orals (plus non-parenteral) Products All regions 01/10/2023 to 31/05/2024 (8months)<br/>Hospital Only Products: DCE & DSW regions 01/10/2023 - 30/09/2025 (24months)<br/>Housekeeping Products (Hospital Only):<br/>DLN & DNW regions 01/10/2023 -31/01/2025 (16 months)<br/>DLS & DNE regions 01/10/2023 -31/05/2024 (8 months)